hubungan antara microsatellite instability (msi

77

DAFTAR PUSTAKA

Abdullah, M., Sudoyo, A.W., Utomo, A.R., Fauzi, A., Rani, A.A. 2012.

Molecular profile of colorectal cancer in Indonesia: Is there another

pathway? Gastroenterol Hepatol. From Bed to Bench. 5, 71–78.

Ahmet Ziya Balta., Yavuz Özdemir., İlker Sücüllü., Serhat Tolga Derici., Mahir

Bağcı., Dilaver Demirel., M.L.A. 2014. Can horizontal diameter of colorectal

tumor help predict prognosis?. Ulus Cer Derg. 30, 115–119.

Ahnen, D.J., Feigl, P., Quan, G., Fenoglio-Preiser, C., Lovato, L.C., Bunn, P.A.

Jr., Stemmerman, G., Well, J.D., Macdonald, J.S., M.F.J. 1998. Ki-ras

mutation and p53 overexpression predict the clinical behavior of colorectal

cancer: a Southwest Oncology Group study. Cancer Res. 58, 1149–1158.

Aimery de Gramont., Marc Buyse., Jose Cortinas Abrahantes., Tomasz

Burzykowski., Emmanuel Quinaux., Andres Cervantes., Arie Figer., Gérard

Lledo., Michel Flesch., Laurent Mineur., Elisabeth Carola., Pierre-Luc

Etienne., Fernando Rivera., Isabel Chirivella., Nathalie, P.C.T. 2007.

Reintroduction of oxaliplatin is associated with improved survival in

advanced colorectal cancer. J Clin Oncol. 25, 3224–3229.

Alexander, J., Watanabe, T., Wu, T.T., Rashid, A., Li, S., H.S. 2001.

Histopathological identification of colon cancer with microsatellite

instability. Am J Pathol. 158(2), 527–535.

American Cancer Society. 2005. Colorectal Cancer Facts & Figures, Special Ed.

ed. Oklahoma City, OK.

American Joint Committee On Cancer. 2010. AJCC CANCER STAGING

MANUAL, Seventh Ed. ed. Springer New York Dordrecht Heidelberg

London, New York.

Andrieu, N., Launoy, G., Guillois, R., Ory-Paoletti, C., Gignoux, M. 2004.

Estimation of the familial relative risk of cancer by site from a French

population based family study on colorectal cancer (CCREF study). Gut. 53,

1322–1328.

Ashktorab, H., Smoot, D.T., Carethers, J.M., Rahmanian, M., Kittles, R.,

Vosganian, G., Doura, M., Nidhiry, E., Naab, T., Momen, B., Shakhani, S.,

Giardiello, F.M. 2003. High Incidence of Microsatellite Instability in

Colorectal Cancer from African Americans. Clin Cancer Res. 9, 1112–1117.

Baba, Y., Nosho, K., Shima, K., Goessling, W., Chan, A., Ng K., Chan, J.,

Giovannucci, E., Fuchs, C., O.S. 2010. PTGER2 overexpression in colorectal

cancer is associated with microsatellite instability, independent of CpG

HUBUNGAN ANTARA MICROSATELLITE INSTABILITY (MSI) BERDASARKAN PENANDA MLH1 DANPMS2 DENGAN GAMBARAN KLINIKOPATOLOGI PASIEN KANKER KOLOREKTAL RIZKA VIDYA LESTARI, Dewi K. Paramita., S.Si., M.Si., Ph.D.; dr. Susanna Hilda H., Ph.D, Sp.PD, KHOMUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

78

island methylator phenotype. Cancer Epidemiol Biomark. Prev. 19, 822–831.

Bailey, C.E., Hu, C.-Y., You, Y.N., Bednarski, B.K., Rodriguez-Bigas, M.A.,

Skibber, J.M., Cantor, S.B., Chang, G.J. 2015. Increasing Disparities in the

Age-Related Incidences of Colon and Rectal Cancers in the United States,

1975-2010. JAMA Surg. 150, 17.

Bert Vogelstein, M.D., Eric R. Fearon, B.A., Stanley R. Hamilton, M.D., Scott E.

Kern, M.D., Ann C. Preisinger, B.A., Mark Leppert, Ph.D., Alida M.M.

Smits, B.S., and Johannes L. Bos, P.D. 1998. Genetic alterations during

colorectal-tumor development. N Engl J Med. 319, 525–532.

Bohorquez, M., Sahasrabudhe, R., Criollo, A., Sanabria-Salas, M.C., Vélez, A.,

Castro, J.M., Marquez, J.R., Mateus, G., Bolaños, F., Panqueva, C.,

Restrepo, J.I., Puerta, J.D., Murillo, R., Bravo, M.M., Hernández, G., Rios,

A., Prieto, R., Tomlinson, I., Echeverry, M., Carvajal-Carmona, L.G. 2016.

Clinical manifestations of colorectal cancer patients from a large multicenter

study in Colombia. Medicine (Baltimore). 95, e4883.

Bonaı, B., Grandjouan, S., Huiart, L., Caron, O., Colas, C., Bonaı, C. 2013. and

MSH6 Genes in Lynch Syndrome. JAMA. 305, 2304–2310.

Bongaerts, B.W., van den Brandt, P.A., Goldbohm, R.A., de Goeij, A.F., W.M.

2008. Alcohol consumption, type of alcoholic beverage and risk of colorectal

cancer at specific subsites. Int J Cancer. 123, 2411–2417.

Chan, G.K., Jablonski, S.A., Sudakin, V., Hittle, J.C., Y.T. 1999. Human BUBR1

is a mitotic checkpoint kinase that monitors CENP-E functions at

kinetochores and binds the cyclosome/APC. J Cell Biol. 146, 941–954.

Colussi, D., Brandi, G., Bazzoli, F., Ricciardiello, L. 2013. Molecular pathways

involved in colorectal cancer: implications for disease behavior and

prevention. Int J Mol Sci. 14, 16365–16385.

Compton, C.C., Fielding, L.P., Burgart, L.J, Conley, B., Cooper, H.S., Hamilton,

S.R., Hammond, M.E., Henson, D.E., Hutter, R.V., Nagle, R.B., Nielsen,

M.L., Sargent, D.J., Taylor, C.R., Welton, M., W.C. 2000. Prognostic factors

in colorectal cancer. College of American Pathologists Consensus Statement

1999. Arch Pathol Lab Med. 124, 979–994.

Domingo, E., Niessen, R.C., Oliveira, C., Alhopuro, P., Moutinho, C., Espin, E.,

Armengol, M., Sijmons, R.H., Kleibeuker, J.H., Seruca, R., Aaltonen, L.A.,

Imai, K., Yamamoto, H., Schwartz, S., Hofstra, R.M.W. 2005. BRAF-V600E

is not involved in the colorectal tumorigenesis of HNPCC in patients with

functional MLH1 and MSH2 genes. Oncogene. 24, 3995–3998.

E Kaku., Oda Y., Murakami, Y., Goto, H., Tanaka, T., H.K., Yasunaga, M., Ito,


79

K., Sakurai, K., Fujimori, T., Hattori, M., S.Y. 2011. Proportion of flat- and

depressed-type and laterally spreading tumor among advanced colorectal

neoplasia. Clin Gastroenterol Hepatol. 9, 503–508.

Ferrari, P., Jenab, M., Norat, T., Moskal, A., Slimani, N., Olsen, A., Tjønneland,

A., Overvad, K., Jensen, M.K., Boutron-Ruault, M.C., Clavel-Chapelon, F.,

Morois, S., Rohrmann, S., Linseisen, J., Boeing, H., Bergmann, M.,

Kontopoulou, D., Trichopoulou, A., Kassapa, C., Masala, G., Krogh, V.,

Vineis, P., Panico, S., Tumino, R., Van Gils, C.H., Peeters, P., Bueno-de-

Mesquita, H.B., Ocké, M.C., Skeie, G., Lund, E., Agudo, A., Ardanaz, E.,

López, D.C., Sanchez, M.J., Quirós, J.R., Amiano, P., Berglund, G., Manjer,

J., Palmqvist, R., Van Guelpen, B., Allen, N., Key, T., Bingham, S., Mazuir,

M., Boffetta, P., Kaaks, R., Riboli, E. 2007. Lifetime and baseline alcohol

intake and risk of colon and rectal cancers in the European Prospective

Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 121, 2065–

2072.

Field K, L.L. 2007. Metastatic colorectal cancer-past, progress and future. World J

Gastroenterol 13, 3806–3815.

Firestein, R., Bass, A.J., Kim, S.Y., Dunn, I.F., Silver, S.J., Guney, I., Freed, E.,

Ligon, A.H., Vena, N., Ogino, S., Chheda, M.G., Tamayo, P., Finn, S.,

Shrestha, Y., Boehm, J.S., Jain, S., Bojarski, E., Mermel, C., Barretina, J.,

Chan, J.A., Baselga, J., Tabernero, J., Root, D.E., Fuchs, C.S., Loda, M.,

Shivda., H.W. 2008. CDK8 is a colorectal cancer oncogene that regulates

beta-catenin activity. Nature. 455, 547–551.

Fishel, R. 1998. Mismatch repair, molecular switches, and signal transduction.

Genes Dev. 12, 2096–2101.

Fleming, M., Ravula, S., Tatishchev, S.F., Wang, H.L. 2012. Colorectal

carcinoma: Pathologic aspects. J Gastrointest Oncol. 3, 153–173.

Fryer CJ, White JB, J.K. 2004. Mastermind recruits CycC:CDK8 to phosphorylate

the Notch ICD and coordinate activation with turnover. Mol Cell. 19, 509–

20.

Fujiyoshi, K., Yamamoto, G., Takenoya, T., Takahashi, A., Arai, Y., Yamada, M.,

Kakuta, M., Yamaguchi, K., Akagi, Y., Nishimura, Y., Sakamoto, H., Akagi,

K. 2017. Metastatic Pattern of Stage IV Colorectal Cancer with High-

Frequency Microsatellite Instability as a Prognostic Factor. Anticancer Res.

37, 239–248.

Gill, S., Lindor, N.M., Burgart, L.J., Smalley, R., Leontovich, O., French, A.,

Goldberg, R.M., Sargent, D.J., Jass, J.R., Hopper, J.L., Jenkins, M.A.,

Young, J., Barker, M.A., Walsh, M.D., Ruszkiewicz, A.R., Thibodeau, S.N.

2005. Isolated loss of PMS2 expression in colorectal cancers: Frequency,


80

patient age, and familial aggregation. Clin Cancer Res. 11, 6466–6471.

Grady, W.M., Markowitz, S.D. 2015. The Molecular Pathogenesis of Colorectal

Cancer and Its Potential Application to Colorectal Cancer Screening. Dig Dis

Sci. 60, 762–772.

Gurjeet, Kaur., Abdelhafd Masoud., N. Raihan., M. Radzi., W.K.& L.S.K. 2011.

Mismatch repair genes expression defects & association with

clinicopathological characteristics in colorectal carcinoma. Indian J Med Res.

134, 186–192.

Haggar, F. a, Boushey, R.P., Ph, D. 2009. Colorectal Cancer Epidemiology :

Incidence , Mortality , Survival , and Risk Factors. Clin Colon Rectal Surg.

6, 191–197.

Hamilton, S.R., Aaltonen, L.A. 2000. World Health Organization classification of

tumours ; Pathology and Genetic of Tumours of the Digestive System.

Herman, J.G., Umar, A., Polyak, K., Graff, J.R., Ahuja, N., Issa, J.-P.J.,

Markowitz, S., Willson, J.K. V., Hamilton, S.R., Kinzler, K.W., Kane, M.F.,

Kolodner, R.D., Vogelstein, B., Kunkel, T.A., Baylin, S.B. 1998. Incidence

and functional consequences of hMLH1 promoter hypermethylation in

colorectal carcinoma. Proc Natl Acad Sci. 95, 6870–6875.

Hinoi, T., Tani, M., Lucas, P.C., Caca, K., Dunn, R.L., Macri, E., Loda, M.,

Appelman, H.D., Cho, K.R., F.E. 2001. Loss of CDX2 expression and

microsatellite instability are prominent features of large cell minimally

differentiated carcinomas of the colon. Am J Pathol. 159, 2239–48.

Huang, C.-W., Tsai, H.-L., Huang, M.-Y., Huang, C.-M., Yeh, Y.-S., Ma, C.-J.,

Wang, J.-Y. 2015. Different clinicopathologic features and favorable

outcomes of patients with stage III left-sided colon cancer. World J Surg

Oncol. 13, 257.

Huang, Y., Yuan, Y., Ge, W., Hu, H., Zhang, S., Zheng, S. 2010. Comparative

features of colorectal and gastric cancers with microsatellite instability in

Chinese patients. J Zhejiang Univ Sci B. 11, 647–653.

International Agency for Research on Cancer. 2008. World Cancer report 2008.

Cancer Control 199, 512.

IO, H., Jess P 2012. Possible better long-term survival in left versus right-sided

colon cancer - a systematic review. Dan Med J. 59, A4444.

Ishikubo, T., Nishimura, Y., Yamaguchi, K., Khansuwan, U., Arai, Y.,

Kobayashi, T., Ohkura, Y., Hashiguchi, Y., Tanaka, Y., Akagi, K. 2004. The

clinical features of rectal cancers with high-frequency microsatellite

instability (MSI-H) in Japanese males. Cancer Lett. 216, 55–62.


81

Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D. 2011. Global

Cancer Statistics: 2011. CA Cancer J Clin. 61, 69–90.

Jiricny, J. 2006. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol.

7, 335–346.

Karahan, B., Argon, A., Yıldırım, M., Vardar, E. 2015. Relationship between

MLH-1, MSH-2, PMS-2, MSH-6 expression and clinicopathological features

in colorectal cancer. Int J Clin Exp Pathol. 8, :4044-4053.

Kawakami, H., Zaanan, A., Sinicrope, F.A., 2016. HHS Public Access 16, 1–14.

Kazama, Y., Watanabe, T., Kanazawa, T., Tanaka, J., Tanaka, T., Nagawa, H.

2007. Microsatellite instability in poorly differentiated adenocarcinomas of

the colon and rectum: relationship to clinicopathological features. J Clin

Pathol. 60, 701–704.

Kelsen, D.P., Van De Velde, C. J. H. Minsky, B.D. 2008. Gastric cancer: clinical

management. In: Kelsen, D.P., Daly, J.M., Kern, S.E., Levin, B., Tepper,

J.E., Van Cutsem, E. (Eds.), Principles and Practice of Gastrointestinal

Oncology. Lippincott Williams & Wilkins, Philadelphia, pp. 285–316.

Kheirelseid, E.A.H., Miller, N., Chang, K.H., Curran, C., Hennessey, E., Sheehan,

M., Kerin, M.J. 2013. Mismatch repair protein expression in colorectal

cancer. J Gastrointest Oncol. 4, 397–408.

Kim, S.E., Paik, H.Y., Yoon, H., Lee, J.E., Kim, N., Sung, M.K. 2015. Sex- and

gender-specific disparities in colorectal cancer risk. World J Gastroenterol.

21, 5167–5175.

Lanza, G., Gafà, R., Maestri, I., Santini, A., Matteuzzi, M., Cavazzini, L. 2002.

Immunohistochemical Pattern of MLH1/MSH2 Expression Is Related to

Clinical and Pathological Features in Colorectal Adenocarcinomas with

Microsatellite Instability. Mod Pathol. 15, 741–749.

Leopoldo S, Lorena B, Cinzia A, Gabriella DC, Angela Luciana B, Renato C,

Antonio M, Carlo S, Cristina P, Stefano C, Maurizio T, Luigi R, C.B. 2008.

Two subtypes of mucinous adenocarcinoma of the colorectum:

clinicopathological and genetic features. Ann Surg Oncol. 15(5), 1429–39.

Li, X., Yao, X., Wang, Y., Hu, F., Wang, F., Jiang, L., Liu, Y., Wang, D., Sun, G.,

Zhao, Y. 2013. MLH1 Promoter Methylation Frequency in Colorectal

Cancer Patients and Related Clinicopathological and Molecular Features.

PLoS One. 8.

Liang, H., Wang, X., Wang, B., Pan, Y., Liu, N., Wang, D., Hao, X. 2006.

Prognostic factors of young patients with colon cancer after surgery 12,

1458–1462.


82

Limsui, D., Vierkant, R.A., Tillmans, L.S., Wang, A.H., Weisenberger, D.J.,

Laird, P.W., Lynch, C.F., Anderson, K.E., French, A.J., Haile, R.W.,

Harnack, L.J., Potter, J.D., Slager, S.L., Smyrk, T.C., Thibodeau, S.N.,

Cerhan, J.R., Limburg, P.J., 2010. Cigarette smoking and colorectal cancer

risk by molecularly defined subtypes. J Natl Cancer Inst. 102, 1012–1022.

Ling, A., Edin, S., Wikberg, M.L., Öberg, Å., Palmqvist, R., 2014. The

intratumoural subsite and relation of CD8+ and FOXP3+ T lymphocytes in

colorectal cancer provide important prognostic clues. Br J Cancer. 110,

2551–2559.

Lingling Cao, Lin Zhu, Jiaxing Yang, Jiaming Su, Jinsong Ni, Yujun Du, Da Liu,

Yanfang Wang, Fei Wang, Jingji Jin1, And Y.C. 2014. Correlation of low

expression of hMOF with clinicopathological features of colorectal

carcinoma, gastric cancer and renal cell carcinoma. Int J Oncol 44, 1207–

1214.

Medicine, J.H. 2011. Sporadic ( Nonhereditary ) Colorectal Cancer : Introduction.

[WWW Document]. Johns Hopkins Med. URL

http://www.hopkinsmedicine.org/gastroenterology_hepatology/diseases_con

ditions/small_large_intestine/sporadic_colorectal_cancer.html

Meyerhardt, J.A., Niedzwiecki, D., Hollis, D., Saltz, L.B., Hu, F.B., Mayer, R.J.,

Nelson, H., Whittom, R., Hantel, A., Thomas, J., Fuchs, C.S. 2007.

Association of Dietary Patterns With Cancer Recurrence and Survival in

Patients With Stage III Colon Cancer. Jama. 298, 754.

Moghimi-Dehkordi, B. 2012. An overview of colorectal cancer survival rates and

prognosis in Asia. World J Gastrointest Oncol. 4, 71.

Mojarad, E.N., Mohammad, S., Kashfi, H., Mirtalebi, H., Taleghani, M.Y.,

Azimzadeh, P., Savabkar, S., Pourhoseingholi, M.A., Jalaeikhoo, H.,

Aghdaei, H.A., Kuppen, P.J.K., Zali, M.R. 2016. Low Level of

Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II

Colorectal Cancer Patients. J Oncol. 2016, 1–9.

Nahas, S.C., Nahas, C.S.R., Bustamante-Lopez, L.A., Pinto, R.A., Marques,

C.F.S., Campos, F.G., Ceconello, I. 2015. Prognostic factors of surgically-

treated patients with cancer of the right colon: a ten years’ experience of a

single universitary institution. Arq Bras Cir Dig. 28, 3–7.

Nosho, K., Kawasaki, T., Ohnishi, M., Suemoto, Y., Kirkner, G.J., Zepf, D., Yan,

L., Longtine, J.A., Fuchs, C.S., Ogino, S. 2008. PIK3CA mutation in

colorectal cancer: Relationship with genetic and epigenetic alterations.

Neoplasia. 10, 534–541.

Park, H.-C., Shin, A., Kim, B.-W., Jung, K.-W., Won, Y.-J., Oh, J.H., Jeong, S.-


83

Y., Yu, C.S., Lee, B.H. 2013. Data on the characteristics and the survival of

korean patients with colorectal cancer from the Korea central cancer registry.

Ann Coloproctol. 29, 144–149.

Parsons, M.T, Buchanan, D.D., Thompson, B., Young, J.P. S.A. 2012. Correlation

of tumour BRAF mutations and MLH1 methylation with germline mismatch

repair (MMR) gene mutation status: a literature review assessing utility of

tumour features for MMR variant classification. J Med Genet. 49, 151–157.

Phipps, A.I., Lindor, N.M., Jenkins, M.A., Baron, J.A., Win, A.K., Gallinger, S.,

Gryfe, R., Polly, A. 2014. NIH Public Access. 56, 937–944.

Pineda, M., Mur, P., Iniesta, M.D., Borràs, E., Campos, O., Vargas, G., Iglesias,

S., Fernández, A., Gruber, S.B., Lázaro, C., Brunet, J., Navarro, M., Blanco,

I., Capellá, G. 2012. MLH1 methylation screening is effective in identifying

epimutation carriers. Eur J Hum Genet. 20, 1256–1264.

Pinheiro, M., Ahlquist, T., Danielsen, S.A., Lind, G.E., Veiga, I., Pinto, C., Costa,

V., Afonso, L., Sousa, O., Fragoso, M., Santos, L., Henrique, R., Lopes, P.,

Lopes, C., Lothe, R.A., Teixeira, M.R. 2010. Colorectal carcinomas with

microsatellite instability display a different pattern of target gene mutations

according to large bowel site of origin. BMC Cancer. 10, 587.

Ricciardiello, L., Ceccarelli, C., Angiolini, G., Pariali, M., Chieco, P., Paterini, P.,

Biasco, G., Martinelli, G.N., Roda, E., Bazzoli., F. 2005. High Thymidylate

Synthase Expression in Colorectal Cancer with Microsatel.lite Instability:

Implications for Chemotherapeutic Strategies. Clin Cancer Res. 11.

Rosty, C., Clendenning, M., Walsh, M.D., Eriksen, S. V, Southey, M.C., Winship,

I.M., Macrae, F.A., Boussioutas, A., Poplawski, N.K., Parry, S., Arnold, J.,

Young, J.P., Casey, G., Haile, R.W., Gallinger, S., Le Marchand, L.,

Newcomb, P.A., Potter, J.D., DeRycke, M., Lindor, N.M., Thibodeau, S.N.,

Baron, J.A., Win, A.K., Hopper, J.L., Jenkins, M.A., Buchanan, D.D. 2016.

Germline mutations in PMS2 and MLH1 in individuals with solitary loss of

PMS2 expression in colorectal carcinomas from the Colon Cancer Family

Registry Cohort. BMJ Open. 6, e010293.

Sandeep, N.S., Suzanne, E.H., Kristin, A.E. 2011. Defective Mismatch Repair,

Microsatellite Mutation Bias, and Variability in Clinical Cancer Phenotypes

70, 431–435.

Shin, H.J., Baek, K.H., Jeon, A.H., Park, M.T., Lee, S.J., Kang, C.M., Lee, H.S.,

Yoo, S.H., Chung, D.H., Sung, Y.C., McKeon, F., L.C. 2003. Dual roles of

human BubR1, a mitotic checkpoint kinase, in the monitoring of

chromosomal instability. Cancer Cell. 4, 483–497.

Singletary, S.E., C.J. 2006. Breast cancer staging: working with the sixth edition


84

of the AJCC Cancer Staging Manual. CA Cancer J Clin. 56, 37–47.

Sinicrope, F.A. 2010. DNA mismatch repair and adjuvant chemotherapy in

sporadic colon cancer. Nat Rev Clin Oncol. 7, 174–177.

Sinicrope, F.A. 2016. The role of microsatellite instability testing in management

of colorectal cancer. Clin Adv Hematol Oncol. 14, 476–479.

SK, P., Hurria A. 2010. Impact of age, sex, and comorbidity on cancer therapy

and disease progression. J Clin Oncol. 28, 4086–4093.

Søreide, K. 2011. High-fidelity of five quasimonomorphic mononucleotide

repeats to high-frequency microsatellite instability distribution in early-stage

adenocarcinoma of the colon. Anticancer Res. 31, 967–971.

Sudoyo, A.W., Hernowo, B., Krisnuhoni, E., Reksodiputro, A.H., Hardjodisastro,

D. 2010. Colorectal cancer among young native Indonesians: A

clinicopathological and molecular assessment on microsatellite instability.

Med J Indones. 19, 245–251.

Thirunavukarasu, P., Sathaiah, M., Singla, S., Sukumar, S., Karunamurthy, A.,

Pragatheeshwar, K.D., Lee, K.K., Zeh, H., Kane, K.M., B.D. 2010.

Medullary carcinoma of the large intestine: a population based analysis. Int J

Oncol. 37, 901–907.

Thomas DC, Umar A, K.T. 1996. Microsatellite instability and mismatch repair

defects in cancer. Mutat Res. 350, 201–205.

Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-tieulent, J., Jemal, A. 2015.

Global Cancer Statistics, 2012. CA a cancer J Clin. 65, 87–108.

Truninger, K., Menigatti, M., Luz, J., Russell, A., Haider, R., Gebbers, J.O.,

Bannwart, F., Yurtsever, H., Neuweiler, J., Riehle, H.M., Cattaruzza, M.S.,

Heinimann, K., Schär, P., Jiricny, J., Marra, G. 2005. Immunohistochemical

analysis reveals high frequency of PMS2 defects in colorectal cancer.

Gastroenterology. 128, 1160–1171.

van Roon, E.H., van Puijenbroek, M., Middeldorp, A., van Eijk, R., de Meijer,

E.J., Erasmus, D., Wouters, K.A., van Engeland, M., Oosting, J., Hes, F.J.,

Tops, C.M., van Wezel, T., Boer, J.M., Morreau, H. 2010. Early onset MSI-

H colon cancer with MLH1 promoter methylation, is there a genetic

predisposition?. BMC Cancer. 10, 180.

Vilar, E., Gruber, S.B. 2010. Microsatellite instability in colorectal cancer—the

stable evidence. Nat Rev Clin Oncol. 7, 153–162.

Wang X, Wan F, Pan J, Yu GZ, Chen Y, W.J. 2008. Tumor size: a nonneglectable

independent prognostic factor for gastric cancer. J Surg Oncol. 97, 236–240.


85

Watson, P., Vasen, H.F.A., Mecklin, J., Bernstein, I., Järvinen, H.J., Myrhøj, T.,

Sunde, L., Wijnen, J.T., T, H. 2009. NIH Public Access Int J. 123, 444–449.

Xiao, H., Yoon, Y.S., Hong, S.M., Roh, S.A., Cho, D.H., Yu, C.S., Kim, J.C.

2013. Poorly differentiated colorectal cancers: Correlation of microsatellite

instability with clinicopathologic features and survival. Am J Clin Pathol.

140, 341–347.

Yiu, R., Qiu, H., Lee, S.-H., García-Aguilar, J. 2005. Mechanisms of

Microsatellite Instability in Colorectal Cancer Patients in Different Age

Groups. Dis Colon Rectum. 48, 2061–2069.

Zhang, B., Halder, S.K., Kashikar, N.D., Cho, Y., Datta, A., Gorden, D.L., Datta,

P.K. 2010. Antimetastatic role of Smad4 signaling in colorectal cancer.

Gastroenterology. 138, 969–980.

Zhang, X., Li, J. 2013. Era of universal testing of microsatellite instability in

colorectal cancer. World J Gastrointest Oncol. 5, 12–19.

Zhi, W., Ying, J., Zhang, Y., Li, W., Zhao, H., Lu, N., Shi, S. 2015. DNA

Mismatch Repair Deficiency in Colorectal Adenocarcinoma and its

Association with Clinicopathological Features. J Clin Exp Pathol. 5.


hubungan antara microsatellite instability (msi

Documents